Liang Ouyang. A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injuryJ. Acta Pharmaceutica Sinica B, 2025, 15(7): 3831-3832. DOI: 10.1016/j.apsb.2025.06.003
|
Citation:
|
Liang Ouyang. A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injuryJ. Acta Pharmaceutica Sinica B, 2025, 15(7): 3831-3832. DOI: 10.1016/j.apsb.2025.06.003
|
Liang Ouyang. A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injuryJ. Acta Pharmaceutica Sinica B, 2025, 15(7): 3831-3832. DOI: 10.1016/j.apsb.2025.06.003
|
Citation:
|
Liang Ouyang. A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injuryJ. Acta Pharmaceutica Sinica B, 2025, 15(7): 3831-3832. DOI: 10.1016/j.apsb.2025.06.003
|
DownLoad: